Contact Sign In
Request Demo
Featured Content
HealthVerity MarketplaceTM

The nation’s largest healthcare and consumer data ecosystem

HealthVerity TaxonomySM

The most comprehensive claims solution for real-world evidence

Life Sciences

Research-ready data solutions from development through commercialization

Identity Manager (HVID)

Standalone de-identification as a service

Data Ecosystem
HealthVerity MarketplaceTM
HealthVerity TaxonomySM
Precision Event Alerts
HealthVerity Mastersets
Media Measurement
Insurance Underwriting
Technology Products
Identity Manager (HVID)
HealthVerity FLOW
Governance Manager
Smart Contracts
Life Sciences

Technology solutions from development through commercialization

Channel Partners

HealthVerity enables partners to unlock unprecedented value and insights for clients

Government

Comprehensive and compliant solutions to manage the nation’s care

Data Ecosystem Partners

Join the nation’s largest data partner ecosystem

Insurance

Insurance-grade solutions that excel in managing risk and rebates

HealthVerity Blog

Insights and updates from industry experts

Publications

Peer-reviewed research and discoveries

News & Events

Stay informed about our latest announcements and happenings

The IPGE Approach

Fundamentals that power everything that we do and every solution we offer

Resource Library

Explore guides, webinars, and tools to enhance your understanding

Zombie Data Explained

Learn how data quality drives better research outcomes

Disparities in OUD treatment: Buprenorphine vs. naltrexone

Understanding disparities in opioid use disorder (OUD) treatment Pharmaceutical companies committed to advancing treatments for opioid use disorder (OUD) must understand the real-world access patients have to medications. A new retrospective study by...

Read more

Contact us